Health & Medicine
-
FDA Okays Novartis Drug 'Xolair' for Chronic Hives
The U.S. Food and Drug Administration (FDA) has approved Xolair (omalizumab) for the treatment of a type of chronic hives, Genetech announced in a statement released Friday.
Latest Research Articles
-
DNA at Crime Scene can be used to Create Offender's Mugshot
-
Computer System Better than Humans in Fake Pain Detection
-
Humans can Smell more than 1 Trillion Odors, Researchers Say
-
High Dose of Statins Control Progress of Multiple Sclerosis
-
Good Bacteria in Guts Ferment Dark Chocolate into Heart Healthy Compounds
-
Chicken Bone DNA Shows Columbus Reached South America before Polynesians
-
Say What? One-Fifth of People Who Need Hearing Aids Don't Wear Them, UK Study Reveals
-
Link Between Saturated fat and Heart Disease Unclear
-
Americans with Headaches get Excessive Brain Scans, Spending $1 Billion Annually, Study Finds
-
Researchers Find Link between Autism and Environmental Toxins
-
Depression Bad for the Heart, Researchers Find
-
Paris Offers Free Transportation to Fight Air Pollution
most popular
-
Beyond the Aurora: How Do Solar Flares Affect Electronics
-
Mauna Loa’s Lava Study Confirms Geologists’ Early Warning of Eruption
-
Global Plastic Pileup Could Be Halted With Four Policies, California Study Finds
-
‘Worsening Smog’ Forces New Delhi to Close All Primary Schools
-
World’s Largest Organism May Have Persisted Since the First Human Migrations
